BCL-2 As a Potential Therapeutic Target in Human Lupus Tubulointerstitial Inflammation.

被引:0
|
作者
Ko, Kichul [1 ]
Yanez, Denisse [1 ]
Kaverina, Natalya [1 ]
Liarski, Vladimir M. [1 ]
Peng, Yahui [2 ]
Lan, Li [1 ]
Perper, Stuart [3 ]
Schwartz, Annette [3 ]
O'connor, Liz [3 ]
Souers, Andrew [4 ]
Elmore, Steven [4 ]
Olson, Lisa [3 ]
Giger, Maryellen L. [1 ]
Wang, Li Chun [3 ]
Clark, Marcus R. [1 ]
机构
[1] Univ Chicago, Chicago, IL 60637 USA
[2] Beijing Jiaotong Univ, Beijing, Peoples R China
[3] AbbVie Inc, AbbVie Biores Ctr, Worcester, MA USA
[4] AbbVie Inc, N Chicago, IL USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2839
引用
收藏
页码:S1241 / S1241
页数:1
相关论文
共 50 条
  • [1] BCL-2 AS A POTENTIAL THERAPEUTIC TARGET IN HUMAN LUPUS TUBULOINTERSTITIAL INFLAMMATION
    Wang, L. C.
    Ko, K.
    Yanez, D.
    Kaverina, N.
    Liarski, V. M.
    Peng, Y.
    Lan, L.
    Perper, S.
    Schwartz, A.
    O'Connor, L.
    Souers, A.
    Elmore, S.
    Olson, L.
    Giger, M. L.
    Clark, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 120 - 120
  • [2] Bcl-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation
    Ko, Kichul
    Wang, Jianing
    Perper, Stuart
    Jiang, Yulei
    Yanez, Denisse
    Kaverina, Natalya
    Ai, Junting
    Liarski, Vladimir M.
    Chang, Anthony
    Peng, Yahui
    Lan, Li
    Westmoreland, Susan
    Olson, Lisa
    Giger, Maryellen L.
    Wang, Li Chun
    Clark, Marcus R.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68 (11) : 2740 - 2751
  • [3] The Pathogenesis and Therapeutic Implications of Tubulointerstitial Inflammation in Human Lupus Nephritis
    Clark, Marcus R.
    Trotter, Kimberly
    Chang, Anthony
    SEMINARS IN NEPHROLOGY, 2015, 35 (05) : 455 - 464
  • [4] BCL-2 as therapeutic target for hematological malignancies
    Perini, Guilherme Fleury
    Ribeiro, Glaciano Nogueira
    Pinto Neto, Jorge Vaz
    Campos, Laura Tojeiro
    Hamerschlak, Nelson
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [5] BCL-2 as therapeutic target for hematological malignancies
    Guilherme Fleury Perini
    Glaciano Nogueira Ribeiro
    Jorge Vaz Pinto Neto
    Laura Tojeiro Campos
    Nelson Hamerschlak
    Journal of Hematology & Oncology, 11
  • [6] Targeting cerebral Bcl-2 expression as a potential therapeutic target in autism: Potential usefulness of human recombinant nerve growth factor
    Boso, Marianna
    di Nemi, Stefania Ucelli
    Barale, Francesco
    Emanuele, Enzo
    MEDICAL HYPOTHESES, 2006, 67 (05) : 1256 - 1257
  • [7] Bax and Bcl-2 Expression in Neuroendocrine Carcinoma of the Lung and Potential for New Therapeutic Target
    Batus, M.
    McFarland, D. C.
    Coon, J.
    Pool, M.
    Walters, K.
    Basu, S.
    Fidler, M. J.
    Bonomi, P.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S512 - S513
  • [8] Bcl-XL but Not Bcl-2 Is a Potential Target in Medulloblastoma Therapy
    Westhoff, Mike-Andrew
    Schuler-Ortoli, Marie
    Zerrinius, Daniela
    Hadzalic, Amina
    Schuster, Andrea
    Strobel, Hannah
    Scheuerle, Angelika
    Wong, Tiana
    Wirtz, Christian Rainer
    Debatin, Klaus-Michael
    Peraud, Aurelia
    PHARMACEUTICALS, 2022, 15 (01)
  • [9] Cannabinoid receptors as potential therapeutic targets for inflammation.
    Makriyannis, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U943 - U943
  • [10] Mcl-1 and bcl-2 expression in neuroendocrine carcinoma (NEC) and potential for new therapeutic target
    Batus, M.
    McFarland, D. C.
    Coon, J.
    Basu, S.
    Pool, M.
    Myint, R.
    Walters, K. K.
    Fidler, M. J.
    Bonomi, P. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)